Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-SG-14
Country
SG
Application Type
National Stage
Patent Status
Issued
Patent Number
Publication Number
Application Number
11201604868Y
IC
NCI
Date Filed
Date Issued
Patent PDF